Wolverine Trading’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $76.1M | Buy |
298,300
+28,300
| +10% | +$7.44M | 0.05% | 237 |
|
|
2025
Q2 | $65.3M | Buy |
270,000
+13,700
| +5% | +$3.42M | 0.07% | 200 |
|
|
2025
Q1 | $67.8M | Buy |
256,300
+1,200
| +0.5% | +$325K | 0.08% | 151 |
|
|
2024
Q4 | $64.9M | Buy |
255,100
+59,800
| +31% | +$16M | 0.06% | 188 |
|
|
2024
Q3 | $62.4M | Sell |
195,300
-30,400
| -13% | -$10.8M | 0.07% | 169 |
|
|
2024
Q2 | $84.3M | Buy |
225,700
+88,200
| +64% | +$29.8M | 0.09% | 122 |
|
|
2024
Q1 | $47.7M | Buy |
137,500
+50,700
| +58% | +$19.2M | 0.05% | 199 |
|
|
2023
Q4 | $39.7M | Buy |
86,800
+21,100
| +32% | +$10.4M | 0.04% | 268 |
|
|
2023
Q3 | $32M | Buy |
65,700
+5,100
| +8% | +$2.4M | 0.03% | 249 |
|
|
2023
Q2 | $26.9M | Buy |
60,600
+17,700
| +41% | +$8.91M | 0.03% | 286 |
|
|
2023
Q1 | $21M | Buy |
+42,900
| New | +$21.2M | 0.03% | 336 |
|
|
2022
Q4 | – | Sell |
-24,800
| Closed | -$12.2M | – | 4427 |
|
|
2022
Q3 | $12.2M | Buy |
24,800
+7,200
| +41% | +$3.5M | 0.02% | 487 |
|
|
2022
Q2 | $8.24M | Sell |
17,600
-8,400
| -32% | -$3.74M | 0.01% | 589 |
|
|
2022
Q1 | $11.4M | Buy |
26,000
+3,100
| +14% | +$1.3M | 0.01% | 634 |
|
|
2021
Q4 | $10.7M | Sell |
22,900
-24,400
| -52% | -$10.8M | 0.01% | 701 |
|
|
2021
Q3 | $18.7M | Buy |
47,300
+16,900
| +56% | +$7.17M | 0.02% | 555 |
|
|
2021
Q2 | $13.4M | Buy |
30,400
+13,200
| +77% | +$5.77M | 0.02% | 569 |
|
|
2021
Q1 | $7.32M | Sell |
17,200
-14,000
| -45% | -$5.59M | 0.01% | 873 |
|
|
2020
Q4 | $12.7M | Buy |
31,200
+3,400
| +12% | +$1.41M | 0.02% | 582 |
|
|
2020
Q3 | $11.2M | Buy |
27,800
+6,900
| +33% | +$2.78M | 0.03% | 493 |
|
|
2020
Q2 | $7.93M | Sell |
20,900
-21,000
| -50% | -$7.86M | 0.02% | 567 |
|
|
2020
Q1 | $13M | Sell |
41,900
-20,700
| -33% | -$6.98M | 0.04% | 342 |
|
|
2019
Q4 | $23M | Sell |
62,600
-16,900
| -21% | -$5.36M | 0.06% | 314 |
|
|
2019
Q3 | $20.5M | Buy |
+79,500
| New | +$22.3M | 0.06% | 277 |
|
|
2019
Q2 | – | Sell |
-119,800
| Closed | -$31.9M | – | 4735 |
|
|
2019
Q1 | $31.9M | Buy |
119,800
+18,000
| +18% | +$5.19M | 0.09% | 162 |
|
|
2018
Q4 | $28.7M | Buy |
101,800
+39,200
| +63% | +$12.4M | 0.08% | 165 |
|
|
2018
Q3 | $21.2M | Buy |
62,600
+33,700
| +117% | +$10.9M | 0.05% | 283 |
|
|
2018
Q2 | $7.77M | Hold |
28,900
| – | – | 0.02% | 621 |
|
|
2018
Q1 | $7.77M | Buy |
28,900
+15,100
| +109% | +$4.09M | 0.02% | 621 |
|
|
2017
Q4 | $3.42M | Buy |
13,800
+1,900
| +16% | +$469K | 0.01% | 1121 |
|
|
2017
Q3 | $2.9M | Sell |
11,900
-2,900
| -20% | -$711K | 0.01% | 1098 |
|
|
2017
Q2 | $3.54M | Sell |
14,800
-4,300
| -23% | -$974K | 0.02% | 875 |
|
|
2017
Q1 | $3.95M | Sell |
19,100
-85,800
| -82% | -$17.7M | 0.02% | 760 |
|
|
2016
Q4 | $21.4M | Sell |
104,900
-1,000
| -0.9% | -$191K | 0.11% | 194 |
|
|
2016
Q3 | $18.6M | Buy |
105,900
+33,400
| +46% | +$5.8M | 0.09% | 242 |
|
|
2016
Q2 | $13.3M | Buy |
+72,500
| New | +$12.9M | 0.08% | 261 |
|
Other funds holding HUM
Wolverine Trading's HUM Position: Q3 2025 in Review
Wolverine Trading increased its Humana (HUM) stake by 35% in Q3 2025, buying an estimated $3.78M and bringing the position to 55,633 shares worth $14.2M. The position accounts for 0.01% of the portfolio, ranked #756.
Wolverine Trading first reported a position in HUM in Q2 2016 and has held it in 34 quarters since. The position peaked at $15.5M in Q4 2023. 892 funds tracked by Wall St. Rank hold HUM as of Q3 2025.
- Wolverine Trading held 55,633 shares of Humana worth $14.2M as of Q3 2025.
- Wolverine Trading bought 14,372 Humana shares in Q3 2025, an estimated $3.78M.
- Humana made up 0.01% of Wolverine Trading's portfolio in Q3 2025, its #756 holding.
- Wolverine Trading first reported a position in Humana in Q2 2016 and has held it in 34 quarters since.
- Wolverine Trading's Humana position peaked at $15.5M in Q4 2023.
- 892 funds tracked by Wall St. Rank held Humana as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.